Search Results (467)

Gleichenella pectinata, known as ‘Star fern’, is a species traditionally used by Amazonian indigenous communities to treat various diseases. The objective of this study was to evaluate the bioactive compounds and antioxidant, antimicrobial, antitumor, and anti-inflammatory activities of G. pectinata leaves. The study included the determination of physicochemical parameters (pH, soluble solids, titratable acidity, moisture, and ash), phytochemical screening, mineral analysis by atomic absorption and quantification of bioactive compounds (vitamin C, organic acids, carotenoids, chlorophylls, and phenols) by liquid chromatography (RRLC). Antioxidant (ABTS and DPPH), antimicrobial (ATCC bacteria and fungi, and multi-resistant strains), antitumor and anti-inflammatory activities were evaluated. The results showed the presence of acetogenins, high concentrations of malic acid (56,559.7 mg/100 g DW), β-carotene (266.6 mg/100 g DW), chlorophyll b (684.7 mg/100 g DW), ferulic acid (3163.5 mg/100 g DW) and quercetin glucoside (945.9 mg/100 g DW). The freeze-dried ethanolic extracts showed greater efficacy against Pseudomonas aeruginosa ATCC (12.0 mg/mL) and multidrug-resistant strains of E. coli (6.6 mg/mL) and P. aeruginosa (6.6 mg/mL). In addition, the extract exhibited moderate antiproliferative activity (IC₅₀: 0.98–1.98 mg/mL) in hepatocellular and cervical carcinoma cell lines. In conclusion, this study provides the first evidence of the antitumor and bioactive potential of G. pectinata, supporting its value as a natural source of functional compounds with potential pharmacological applications. Full article

The Lactobacillaceae family encompasses microorganisms of exceptional ecological and biotechnological importance, serving as central agents in food fermentations, health applications, and nutrient cycling across diverse environments. Despite their broad functional and phylogenetic diversity, the global distribution and ecological specialization of Lactobacillaceae are not yet fully understood. In this study, we performed a comprehensive analysis of over 2 million records from the NCBI database to survey and trace the ecological landscape of Lactobacillaceae across thousands of distinct habitats. Our results reveal that food products and animal hosts represent the primary ecological niches for members of this family. The examined taxa exhibit a broad spectrum of ecological strategies, ranging from generalists with wide environmental adaptability to specialists with strict niche preferences. Notably, our findings highlight a profound geographical and ecological sampling bias, with unclassified taxids frequent in animal gastrointestinal tracts, soils, and especially in living plant tissues—habitats identified as promising frontiers for discovering novel biodiversity. The obtained results emphasize the urgent need for expanded sampling efforts in underexplored geographic regions such as Africa, Antarctica, the Arctic, South America, and Central Asia to capture a more complete picture of Lactobacillaceae diversity. The study underscores the necessity of implementing standardized, metadata-rich data deposition practices to enable unbiased, large-scale ecological and evolutionary analyses. Ultimately, these insights not only deepen our fundamental knowledge of Lactobacillaceae diversity but also provide a strategic framework for future bioprospecting, fostering the discovery of novel strains and expanding the biotechnological potential of this influential bacterial family. Full article

Venomous snakes constitute ecologically significant and medically relevant organisms due to the risks associated with their bites, which frequently result in secondary infections. The oral microbiota of these reptiles plays a crucial role in the pathogenesis of such infections; however, its diversity and clinical implications remain insufficiently characterized. This is the first comprehensive review to systematically trace the methodological evolution in snake oral microbiota research, documenting the paradigm shift from traditional culture-dependent techniques to advanced culture-independent approaches, including next-generation sequencing and metagenomics. Our analysis uniquely demonstrates the transformative impact of these technological advances on bacterial diversity identification and antimicrobial resistance gene detection in venomous species. Environmental factors, captivity conditions, and venom composition significantly influence microbial community structure and resistance profiles. These intricate interactions are essential for improving clinical management of snakebite infections, informing empirical antibiotic therapy protocols, and guiding antivenom production strategies. Additionally, the potential of snake oral microbiota as a source of novel bioactive compounds represents an emerging area of bioprospecting research. This review uniquely bridges microbiology, venomics, and clinical medicine, demonstrating the necessity for integrative, multidisciplinary approaches to fully elucidate the ecological and biomedical significance of oral microbial communities in venomous snakes. Full article

Larrea cuneifolia Cav. (common name: jarilla macho) is an endemic Argentinian medicinal shrub that has traditionally been used by the Diaguita-Calchaquí communities in the Monte Desert region in northwestern Argentina. The aim of the present study was to analyze the phytochemical profile and biological activity of the aerial parts of jarilla collected in different places throughout the year, in different seasons and times of day, to determine the optimal harvesting conditions for promoting its medicinal use. The aerial parts were collected three times a day over the course of four seasons in eight L. cuneifolia populations. The total phenolic compounds (TPCs), total flavonoid (TF) content, total lignans (TL), sugars (S) and soluble protein (SP) content were quantified by using spectrophotometric methods and HPLC-DAD. Antioxidant activity was determined by using ABTS scavenging. Significant seasonal, diurnal and spatial variations in the accumulation of TPC (52.61 to 113.52 mg GAE/g), TF (3.71 to 17.92 mg QE/g), TL (283 to 582 μg NDHGAE/g); S (5.73 to 15.17 mg GE/g) and SP (36.75 to 103.10 mg BSAE/g) in aerial parts of L. cuneifolia were revealed. The highest concentrations of TPC and TF were recorded in spring mornings. Maximum accumulation of nordihydroguaiaretic acid (291.8 ± 2.8 μg NDHGAE/mg dry weight) and other lignans were also observed in spring. Heat map analyses pinpoint Ampimpa (Site 1) as a site for jarilla sustainable harvesting, balancing high metabolite content with population abundance, especially in spring, when the highest antioxidant activity (SC₅₀ = 1.560 ± 0.021 μg GAE/mL) coincides with increased phenol levels. These studies highlight the importance of integrating ecological and phytochemical data to define harvesting strategies; collecting during spring mornings optimizes the yield of bioactive compounds, simultaneously minimizing ecological pressure. This study demonstrates how seasonal bioprospecting can inform pharmacological research and local development while safeguarding the endemic plant population. Full article

Antimicrobial resistance (AMR) poses a major global threat to human health. Among multidrug-resistant pathogens, MRSA is a leading cause of severe nosocomial infections, urgently demanding the discovery of novel antimicrobial agents. Nature, particularly Actinomycetota, remains a prolific source of potent bioactive compounds to combat pathogens. This review analyzes recent advancements in anti-MRSA compounds from Actinomycetota. We highlight the most promising bioactive metabolites, their sources, mechanisms of action, and current limitations. Our analysis identified numerous compounds with potent activity against MRSA, including chromomycins, actinomycins, diperamycin, lunaemycin A, lactoquinomycin A, and weddellamycin, which exhibit submicromolar minimal inhibitory concentrations (MICs). The renewed interest in exploring Actinomycetota de novo is directly driven by the AMR crisis. Furthermore, bioprospecting efforts in underexplored ecological niches, such as mangroves and marine sediments, have proven highly promising, as these habitats often harbour unique microbial communities producing novel metabolites. These findings underscore the critical importance of ecology-driven drug discovery in expanding the antimicrobial arsenal and effectively addressing the global health challenge of MRSA and other resistant pathogens. Full article

Marine diatoms are prolific producers of bioactive metabolites, but Arctic species remain underexplored as sources of antibacterial and antibiofilm agents. Here, seven species were grown in photobioreactors (PBRs) and systematically screened for antibacterial, antibiofilm, and cytotoxic activities. All strains inhibited Gram-positive bacteria, and four reduced Staphylococcus epidermidis biofilm formation. Porosira glacialis emerged as a lead species, combining potent antibiofilm activity with favourable traits for large-scale cultivation, and no detectable cytotoxicity. Bioactivity-guided fractionation of P. glacialis yielded two antibiofilm compounds: methyl 3-hydroxyoctadecanoate, the first time reported in diatoms and newly associated with antibiofilm bioactivity, and pheophorbide a, a chlorophyll degradation product. Both inhibited S. epidermidis biofilm formation without any observed cytotoxicity. Notably, Cylindrotheca closterium exhibited cultivation-dependent antibiofilm activity, underscoring the importance of growth conditions for metabolite production. These findings highlight the potential of Arctic diatoms as a sustainable source of antibiofilm agents and support further exploration of their metabolites for antimicrobial and industrial applications. Full article

Marine biotechnology is an emerging field of research. There is scientific evidence of the strong potential of a multitude of marine microorganisms in biotechnology, with applications spanning the medical, pharmaceutical, cosmeceutical, nutraceutical and environmental recovery fields. However, despite the discovery of new natural compounds being of wide-ranging benefit, their practical application still remains difficult due to costs and lengthy validation processes. The strength of natural compounds is that, unlike synthetic or already-known compounds, they can have more specific functions and are generally environmentally friendly. This requires, however, that each newly discovered compound be assayed for its toxicity through tests on model cells and organisms. Research should therefore not stop with the simple discovery of new compounds but go beyond with the validation of their efficacy and safety, an issue that remains poorly addressed for products of marine bacterial origin. This review analyses current knowledge on natural compounds of marine bacterial origin, trying to focus on the necessary steps after their discovery, including the investigation of their non-toxicity to model organisms. Full article

Biological control with beneficial bacteria offers a sustainable alternative to synthetic agrochemicals for managing plant pathogens and enhancing plant health. However, bacterial biocontrol agents (BCAs) remain underexploited due to regulatory hurdles (such as complex registration timelines and extensive dossier requirements) and limited strain characterization. Recent advances in omics technologies (genomics, transcriptomics, proteomics, and metabolomics) have strengthened the bioprospecting pipeline by uncovering key microbial traits involved in biocontrol. Genomics enables the identification of biosynthetic gene clusters, antimicrobial pathways, and accurate taxonomy, while comparative genomics reveals genes relevant to plant–microbe interactions. Metagenomics uncovers unculturable microbes and their functional roles, especially in the rhizosphere and extreme environments. Transcriptomics (e.g., RNA-Seq) sheds light on gene regulation during plant-pathogen-bacteria interactions, revealing stress-related and biocontrol pathways. Metabolomics, using tools like Liquid Chromatography–Mass Spectrometry (LC-MS) and Nuclear Magnetic Resonance spectroscopy (NMR), identifies bioactive compounds such as lipopeptides, Volatile Organic Compounds (VOCs), and polyketides. Co-culture experiments and synthetic microbial communities (SynComs) have shown enhanced biocontrol through metabolic synergy. This review highlights how integrating omics tools accelerates the discovery and functional validation of new BCAs. Such strategies support the development of effective microbial products, promoting sustainable agriculture by improving crop resilience, reducing chemical inputs, and enhancing soil health. Looking ahead, the successful application of omics-driven bioprospection of BCAs will require addressing challenges of large-scale production, regulatory harmonization, and their integration into real-world agricultural systems to ensure reliable, sustainable solutions. Full article

Plant growth-promoting bacteria (PGPBs) offer a sustainable alternative for enhancing crop productivity in low-fertility tropical soils. In this study, 30 bacterial isolates were screened in vitro for multiple PGP traits, including phosphate solubilization (from aluminum phosphate—AlPO₄ and thermophosphate), potassium release from phonolite rock, siderophore production, indole-3-acetic acid (IAA) synthesis, ACC deaminase activity, and antagonism against Fusarium spp. Statistical analysis revealed significant differences (p < 0.05) among the isolates. The most efficient isolates demonstrated a solubilization capacity ranging from 24.0 to 45.2 mg L⁻¹ for thermophosphate and 21.7 to 23.5 mg L⁻¹ for potassium from phonolite. Among them, Pseudomonas azotoformans K22 showed the highest AlPO₄ solubilization (16.6 mg L⁻¹). IAA production among the isolates varied widely, from 1.34 to 9.65 µg mL⁻¹. Furthermore, 17 isolates produced carboxylate-type siderophores, and only Pseudomonas aeruginosa SS183 exhibited ACC deaminase activity, coupled with strong antifungal activity (91% inhibition). A composite performance index identified P. azotoformans K22, E. hormaechei SS150, S. sciuri SS120, and B. cereus SS18 and SS17 as the most promising isolates. This study provides a valuable foundation for characterizing plant growth-promoting traits and identifies key candidates for future validation and the development of microbial consortia. Full article

Infections caused by Staphylococcus aureus pose significant public health challenges, particularly due to antibiotic-resistant strains like MRSA. In this context, Streptomyces, a genus known for producing natural antibiotics, emerges as a promising source for novel therapeutic agents. In this study, a bibliometric analysis of the scientific literature (2015–2024) on Streptomyces as antibiotic biofactories against S. aureus was performed, aiming to identify publication trends, collaborative networks, and emerging research areas. Using the Web of Science database, searches were performed with descriptors (“Streptomyces” AND “Staphylococcus aureus”), including original articles and reviews in English. Data were analyzed with VOSviewer and Biblioshiny to visualize collaborative networks, keyword co-occurrences, and trends. A total of 755 articles from 3705 authors were analyzed, highlighting significant collaboration (98.7%). Publications showed marked growth, particularly in Microbiology (21.7%), Pharmacology and Pharmacy (16.8%), and Biotechnology and Applied Microbiology (16.1%). China and India led in publication volume, whereas the United States exhibited the highest citation impact. Key emerging research topics include biosynthesis and metabolic optimization, antimicrobial activity and bioprospecting, mechanisms of antibiotic action and bacterial resistance, and genomic analyses. Research on Streptomyces for antibiotic production against S. aureus demonstrates continuous expansion and global interest, emphasizing the importance of international collaboration and multidisciplinary approaches. Future studies should intensify exploration of biodiverse environments, genetic engineering applications, and combinatorial strategies to effectively address antimicrobial resistance. Full article

This study reports the isolation and optimization of cellulase-producing bacteria from the gastrointestinal tract of South African goats for the pretreatment of lignocellulosic biomass in bioenergy applications. Among the isolates, three strains, Bacillus KC50, Bacillus KC70, and Proteus mirabilis KC94, were identified by 16S rDNA sequencing. To our knowledge, this is the first report of cellulolytic optimization in P. mirabilis derived from goat rumen. Enzyme production was optimized under varying pH, temperature, and incubation conditions. P. mirabilis KC94 exhibited robust enzyme activity at pH 7 and 35 °C, with stability across a broader range than the Bacillus strains. Peak activity occurred at 84 h of incubation, reflecting strain-specific metabolic adaptation. The presence of organic solvents and surfactants inhibited enzyme activity, whereas mild oxidative stress induced by H₂O₂ stimulated cellulase production. Amplification of GH39, GH45, and GH48 genes revealed KC94’s strong genetic potential for efficient lignocellulose degradation. These findings highlight the biotechnological potential of rumen-derived cellulolytic bacteria, particularly P. mirabilis KC94, for advancing sustainable bioenergy systems. Full article

This study explores the direct effects of amphibian skin secretions on human cells involved in joint diseases, aiming to identify species with potential for inflammatory modulation. Secretions were obtained from sixteen species distributed across Brazilian biomes and one European species. Following biochemical characterization, human chondrocytes, synoviocytes, and macrophages were treated with secretions for 24 h. The cytotoxicity and modulation of the IL-6, IL-8, TNF-α, and IL-1β release were assessed. Synoviocytes showed the greatest resistance to cytotoxic effects, though sensitivity varied by species. Secretions from Trachycephalus mesophaeus, Pipa carvalhoi, and Phyllomedusa bahiana exhibited the highest cytotoxicity. At non-cytotoxic concentrations, P. carvalhoi and Leptodactylus fuscus strongly induced IL-6 and IL-8 in chondrocytes and synoviocytes, with P. carvalhoi also stimulating IL-1β and TNF-α release in macrophages. Among Bufonidae species, particularly Rhinella jimi and Bufo bufo, were potent inducers of TNF-α and IL-1β in macrophages. Secretions lacking pro-inflammatory effects were further tested for anti-inflammatory activity. P. bahiana reduced TNF-α production in stimulated macrophages and IL-6 in synoviocytes, while Siphonops annulatus and T. mesophaeus reduced LPS-induced TNF-α in macrophages. Our data underscore the rich biodiversity of amphibians, supporting the bioprospecting of their cutaneous secretions. These data reveal substantial potential for uncovering bioactive compounds with pharmacological applications. Full article

Oxidative stress, a state resulting from an imbalance between the generation of reactive oxygen species (ROS) and the body’s antioxidant capacity, is a significant contributor to the development of various human pathologies, including malignancies, cardiovascular conditions, neurodegenerative disorders, and the aging process. Antioxidants, both enzymatic and non-enzymatic, are vital in neutralizing free radicals and protecting against cellular damage. Given the limitations of synthetic antioxidants, such as potential toxicity and variable effectiveness, there has been a growing focus on biotechnological methods for producing these essential compounds. This review, titled “Engineering Antioxidants with Pharmacological Applications: Biotechnological Perspectives”, explores the latest developments in this field by examining how biological systems are being utilized to create a wide range of antioxidants. We discuss key production strategies, including the use of microbial cell factories, enzyme-driven synthesis, plant cell cultures, and metabolic engineering. The review provides specific examples of biotechnologically derived antioxidants, such as enzymatic defenses like superoxide dismutase, catalase, and glutathione peroxidase, as well as non-enzymatic molecules like carotenoids, polyphenols, and vitamins. We also evaluate the therapeutic potential of these bio-engineered antioxidants, analyzing preclinical and clinical data on their effectiveness in disease prevention and treatment. The mechanisms by which these compounds combat oxidative stress are also discussed. Finally, we address the current hurdles in scaling up production and managing costs while also outlining future research avenues, such as the creation of new production systems, advanced delivery technologies, and the discovery of novel antioxidant compounds through bioprospecting and synthetic biology. This comprehensive review highlights the potential of biotechnology to offer sustainable and impactful solutions for managing oxidative stress and enhancing overall health. Full article

The need to reduce anthropogenic greenhouse gas emissions drives the development of innovative carbon dioxide capture technologies. Microalgae-based biotechnologies represent a promising approach in this field. In this study, we evaluated the CO₂ assimilation efficiency of two novel microalgae strains, Desmodesmus armatus ARC-06 and Tribonema minus ARC-10, under low (0.04%) and high (1.5%) CO₂ conditions in a periodic cultivation system. The two strains exhibited distinct CO₂ adaptation strategies. D. armatus demonstrated higher tolerance to low CO₂ conditions, whereas T. minus showed superior performance under elevated CO₂. Although elevated CO₂ stimulated growth in both strains, their carbon dioxide sequestration efficiency (CDSE) differed markedly. The maximum CDSE was significantly higher in T. minus (30.0 ± 1.52%) compared to D. armatus (16.5 ± 1.12%). Similarly, the average CDSE over the cultivation period was greater in T. minus (19.1 ± 2.18%) than in D. armatus (11.8 ± 1.45%). These results underscore the importance of bioprospecting for novel microalgae strains, and the need for further research to develop efficient biological CO₂ sequestration methods. Full article

With the goal of bioprospecting for growth-promoting endophytes that could become yield-enhancing inoculants in maize agriculture, we isolated 129 endophytic bacteria from 22 wild plants growing in a nature preserve and an urban park in Cali, Colombia. These strains were put through a bioassay with surface-sterilized seeds of perennial ryegrass (Lolium perenne) grown in sealed tubes, and growth promotion assessed by measuring plant fresh weight. The top two strains Pseudomonas delhiensis and Serratia marcescens, along with five different subcultured root endophytic communities, were put into a secondary screen along with two uninoculated controls of untreated and surface-sterilized seed of both the turfgrass and a commercial maize hybrid. Impact on plant microbiomes was assessed using molecular fingerprinting and high-throughput sequencing. This second bioassay indicated that plant growth promotion was corelated not with inoculation but with seed surface sterilization which shifted root microbiomes, increased endophyte diversity and probably eliminated pathogens. Inoculating maize (but not ryegrass) seed with either pure bacteria or microbial communities was also able to shift the root microbiome. Because the majority of plant microbiome researchers employ seed surface sterilization as a method to standardize their experiments, they could be inadvertently studying unusual plant phenotypes and microbiomes; a possible reason why field trials correlate poorly with those of lab tests. Full article